Leverage reliable competent cells and quality antigens with faster, more diverse antibody libraries.

Phage display remains one of the most powerful methods for antibody discovery. But success depends on two things: generating diverse libraries and screening them against high-quality antigens.

At LGC, we provide both. Our high-efficiency competent cells from Biosearch Technologies enable the construction of large antibody libraries, while our broad portfolio of native and recombinant antigens from The Native Antigen Company supports robust and reliable screening.

Together, these solutions give you the scale, precision, and confidence needed to accelerate your antibody discovery pipeline, all from one supplier.

Why researchers choose LGC

• Larger antibody libraries with greater diversity
  Our competent cells deliver industry-leading transformation efficiency for bigger libraries and more opportunities to find the right binder.

• High-quality antigens for reliable screening
  Choose from an extensive collection of native-like and recombinant antigens, manufactured to preserve functional activity and maximise screening success.

• Workflow continuity from start to finish
  From library construction to antigen screening, we provide a seamless, workflow designed for reproducibility and speed while reducing vendor complexity.

• Trusted quality
  ISO 13485 certification for competent cells and ISO 9001 for antigens, combined with rigorous QC testing, ensure our products meet the highest standards. With LGC, you can be confident you are using the best possible products for your project.
  

Fill out the form to enquire about our competent cells and antigens.